Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Hypertension Drugs Market Research Reports

Titlepublishedprice

Investigation Report on China's Amlodipine Market, 2018-2022

By China Research and Intelligence
"...... inese adults has high blood pressure. With the increasing number of hypertensive patients, the market size of antihypertensive drugs is also growing. Amlodipine is a third-generation calcium antagonist used to treat chronic stable angi......"
13-Dec-2018$2200

Investigation Report on China's Telmisartan Market, 2018-2022

By China Research and Intelligence
"...... ntagonists (angiotensin receptor blockers, ARBs) are antihypertensive drugs that has been growing rapidly since it emerged in the 1990s. As an important ARB administered orally once a day to treat essential hypertension, Telmisartan w......"
13-Dec-2018$2200

Investigation Report on China's Metoprolol Market, 2018-2022

By China Research and Intelligence
"...... he global total. The incidence of hypertension in China rose from 5.1% in 1959 to 37.2% in 2017 by 32.1%. With so many hypertensive patients, China's antihypertensive drug market is growing steadily. There are various antihypertensive drugs i......"
14-Nov-2018$2200

Global Hypertension Partnering 2012 to 2018

By Current Partnering
"...... port provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry......"
01-Oct-2018$1995

Investigation Report on China's Irbesartan Market, 2018-2022

By China Research and Intelligence
"...... thus have replaced the ACEIs in some clinical uses. As a result, the growth of the ACEI market slows down, which leading to a steady increase in the Sartans market. Another growth driver is the new edition of List of Medicines Covered by National Ba......"
14-Sep-2018$2200

Investigation Report on Chinese Valsartan Market, 2018-2022

By China Research and Intelligence
"...... lower blood pressure. Valsartan tablets are mainly used to treat mild to moderate primary hypertension. The growing economy has greatly changed the life style and diet of Chinese people and led to the increasing incidence of hypertension in C......"
05-Jul-2018$2200

Investigation Report on China Nifedipine Market, 2010-2019

By China Research and Intelligence
"...... e, 2.5 million rheumatic heart disease and 5 million congenital heart disease. And one out of five adults suffers from cardiovascular disease which is the leading killer of human health. During the period of 2002-2013, coronary heart disease reported......"
18-Aug-2015$2000

Investigation Report on China Telmisartan Market, 2010-2019

By China Research and Intelligence
"...... applied in the clinic, 8 kinds of similar drugs have come out for sale and there are also 5 kinds of generic drugs in China. In recent years, telmisartan could be said as the fastest-growing kind of dyazide. First developed by Boehringer-Ing......"
18-Jun-2015$2000

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy